Dhruvil Gandhi, MD
Colon & Rectal Surgery · Vista, CANPI 1083887277
Payments from drug & device makers
What this record shows
This record is dominated by education: $12,000 of the $17,161 with a category attached, or 69.9%. Intuitive Surgical accounts for 85.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $9,513 and has fallen 53.1% since, to $4,464 in 2025.
Across 45 payments — averaging $381.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$15K
- Medtronic$1K
- THD America, Inc.$530
- Mimedx Group, Inc.$369
- Aroa Biosurgery Incorporated$35
- KCI USA, Inc.$31
- plus $29 from 2 others
What the payments were for
- Consulting fees$1,4639%
- Travel & lodging$9976%
- Food & beverage$2,70116%
- Education$12,00070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 30 | $14,704 |
| Medtronic | 2 | $1,463 |
| THD America, Inc. | 4 | $530 |
| Mimedx Group, Inc. | 4 | $369 |
| Aroa Biosurgery Incorporated | 2 | $35 |
| KCI USA, Inc. | 1 | $31 |
| Johnson & Johnson | 1 | $16 |
| Coloplast | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$13,751
How this compares
$17,161 in reported general payments places this provider in the 80th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 21 | $105 |
| Tramadol Hcl | 25 | $65 |
| Metronidazole | 25 | $64 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Vista
- Sang LeeLos Angeles$2.4M
- Pamela LeeSan Diego$544K
- Elizabeth RaskinSacramento$126K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
- Joseph CarmichaelOrange$99K
- Phillip FleshnerWest Hollywood$95K
- Zuri MurrellBeverly Hills$86K
- Lorenc MalellariBakersfield$78K
- Ankit SarinSacramento$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.